A pilot study to investigate the muscle strength of children infected with HIV

International Journal of Therapy and Rehabilitation

Volumn 21, Issue 1, 2014, Pages 19-24

  Humphries, Carolyn ^a   Potterton, Joanne ^a   Mudzi, Witness ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Antiretroviral therapy; Children; HIV; Muscle strength

Indexed keywords

EID: 84904471792     PISSN: 17411645     EISSN: 1759779X     Source Type: Journal    
DOI: 10.12968/ijtr.2014.21.1.19     Document Type: Article

References (32)

1. Bäckman E, Odenrick P, Henriksson KG, Ledin T (1989) Isometric muscle force and anthropometric values in normal children aged between 3. 5 and 15 years. Scand J Rehabil Med 21 (2): 105-14.
2. Bale JF Jr, Contant CF, Garg B, Tilton A, Kaufman DM, Wasiewski W (1995) Neurologic history and examination results and their relationship to human immunodeficiency virus type 1 serostatus in hemophiliac subjects: results from the hemophilia growth and development study. Pediatrics95 (2): 215.
3. Baillieu N, Potterton J (2008) The Extent of Delay of Language, Motor and Cognitive Development in HIV Positive Infants. J Neurol Phys Ther 32 (3): 118-21.
4. Blanchette N, Smith ML, King S, Fernandes-Penney A, Read S (2002) Cognitive Development in School-Age Children With Vertically Transmitted HIV Infection. Dev Neuropsychol 21 (3): 223-41.
5. Bohannon RW (2006) Test-retest reliability of the MicroFET 4 hand-grip dynamometer. Physiother Theory Pract 22 (4): 219-21.
6. Buchacz K, Cervia JS, Lindsey JC, Hughes MD, Seage GR 3rd, Dankner WM et al (2003) Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in hiv-infected children. Pediatrics 108 (4): E72.
7. Chantry C, Moye J (2005) Growth, nutrition and metabolism. In: Zeichner S, Zeichner J (eds) Read, Textbook of Pediatric HIV Care. Cambridge University Press, Cambridge.
8. Chakraborty R (2005) HIV-1 Infection in Children: A Clinical and Immunologic Overview. Curr HIV Res 3 (1): 31-41.
9. Chiriboga CA, Fleishman S, Champion S, Gaye-Robinson L, Abrams EJ (2005) Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART). J Pediatr 146 (3): 402-7.
10. Gajdosik C (2005) Ability of very young children to produce reliable isometric force measurements. Pediatr Phys Ther17 (4): 251-7.
11. Grinspoon S, Corcoran C, Rosenthal D, Stanley T, Parlman K, Costello M et al (1999) Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab 84 (1): 201-6.
12. Hsu JWC, Pencharz PB, Macallan D, Tomkins A (2005) Macronutrients and HIV/AIDS: a review of current evidence Consultation on Nutrition and HIV/AIDS in Africa: Evidence, lessons and recommendations for action. Department of Nutrition for Health and Development World Health Organization, Geneva.
13. Llorente A, Brouwers P, Charurat M, Magder L, Malee K, Mellins C et al (2003) Early neurodevelopmental markers predictive of mortality in infants infected with HIV-1. Dev Med Child Neurol 45 (2): 76-84.
14. Lwin R, Melvin D (2001) Annotation: Pediatric HIV Infection. J Child Psychol Psychiatry 42 (4): 427-38.
15. Macfarlane TS, Larson CA, Stiller C (2008) Lower extremity muscle strength in 6-to 8-year-old children using hand-held dynamometry. Pediatr Phys Ther 20 (2): 128-36.
16. McCoig C, Castrejón MM, Castaño E, De Suman O, Báez C, Redondo W et al (2002) Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy. J Pediatr 141 (1): 36-44.
17. Mitchell CD (2006) HIV-1 encephalopathy among perinatally infected children: Neuropathogenesis and response to highly active antiretroviral therapy. Ment Retard Dev Disabil Res Rev 12 (3): 216-22.
18. Msellati P, Lepage P, Hitimana DG, Van Goethem C, Van de Perre P, Dabis F (1993) Neurodevelopmental Testing of Children born to Human Immunodeficiency Virus Type 1 Seropositive and Seronegative Mothers: A Prospective Cohort Study in Kigali, Rwanda. Pediatrics 92 (6): 843-8.
19. Nachman SA, Lindsey JC, Pelton S, Mofenson L, McIntosh K, Wiznia A et al (2002) Growth in Human Immunodeficiency Virus-Infected Children Receiving Ritonavir-Containing Antiretroviral Therapy. Arch Pediatr Adolesc Med 156 (5): 497-503.
20. O'Brien K, Tynan AM, Nixon S, Glazier RH (2008) Effects of progressive resistive exercise in adults living with HIV/AIDS: systematic review and meta-analysis of randomized trials Effects of progressive resistive exercise in adults living with HIV/AIDS: systematic review and meta-analysis of randomized trials. AIDS Care 20 (6): 631-53.
21. Parks, R. A. and Danoff, J. V. (1999) Motor Performance changes in Children Testing Positive for HIV over 2 years. Am J Occup Ther 53 (5): 524-8.
22. Pearson DA, McGrath NM, Nozyce M, Nichols SL, Raskino C, Brouwers P et al (2000) Predicting HIV Disease Progression in Children Using Measures of Neuropsychological and Neurological Functioning. Pediatrics 106 (6): e76.
23. Potterton J, Eales C (2001) Prevalence of developmental delay in infants who are HIV positive. S Afr J Physiother 57 (3): 11-15.
24. Potterton J, Stewart A, Cooper P, Goldberg L, Gajdosik C, Baillieu N (2009) Neurodevelopmental delay in children infected with human immunodeficiency virus in Soweto, South Africa. Vulnerable Child Youth Stud 4 (1): 48-57.
25. Raskino C, Pearson DA, Baker CJ, Lifschitz MH, O'Donnell K, Mintz M et al (1999) Neurologic, Neurocognitive, and Brain Growth Outcomes in Human Immunodeficiency Virus-Infected Children Receiving Different Nucleoside Antiretroviral Regimens. Pediatrics 104 (3): e32.
26. Stein, A, Krebs, G, Richter, L, Tomkins, A, Rochat, T. and Bennish, M. (2005) Babies of a pandemic. Arch Dis Child 90 (2): 116-8.
27. Tepper VJ, Farley JJ, Rothman MI, Houck DL, Davis KF, Collins-Jones TL (1998) Neurodevelopmental/neuroradiologic recovery of a child infected with HIV after treatment with combination antiretroviral therapy using the HIV-specific protease inhibitor ritonavir. Pediatrics 101 (3): E7.
28. UNAIDS (2013) Report on the global HIV/AIDS epidemic. www. unaids. org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en. pdf (accessed 30 December 2013).
29. UNAIDS (2010) Progress Report on Declaration of Commitment on HIV and AIDS, Republic of South Africa. http://data. unaids. org/pub/report/2010/southafrica_2010_country_progress_report_en. pdf (accessed 30 December 2013).
30. UNICEF (2010) Statistics: South Africa. UNICEF South Africa, Pretoria. www. unicef. org/infobycountry/southafrica_statistics. html#89 (accessed 13 March 2012).
31. WHO (2006) Taking Stock: HIV in children, the state of affairs. WHO, Geneva. www. who. int/hiv/toronto2006/takingstockchildren. pdf (accessed 6 July 2008).
32. Yarasheski KE, Tebas P, Stanerson B, Claxton S, Marin D, Bae K et al (2001) Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy. J Appl Physiol (1985) 90 (1): 133-8.